Oral Cancer Research: Oral Cancer Patients Needed
Links shared publicly online about this topic.
- 1,341total visits
Oral Cancer Research: Oral Cancer Patients Needed
View full resource at fightoralcancer.org
Tags: Cancer, Hospital, Hospitals
Most Recently Shared on March 3, 2010 at 6:23 pm By:
Oral Cancer Research: Oral Cancer Patients Needed http://is.gd/9CpPi
Vemurafenib Extends Survival To 16 Months For Some Patients With Metastatic Melanoma
medicalnewstoday.com — “An international team of researchers from the United States and Australia, including researchers at Moffitt Cancer Center in Tampa, Fla., have found that the oral BRAF inhibitor vemurafenib (PLX40” View full resource at medicalnewstoday.com
Most Recently Shared on March 20, 2012 at 7:05 am By:
Vemurafenib Extends Survival To 16 Months For Some Patients With Metastatic Melanoma http://t.co/4ADvhzXF #skincancer #melanoma
Oral Cancer Drugs Not Effective When Mixed With Some Other Medications - QualityPoint Technologies
qualitypointtech.net — “A study, which is being presented at the 2012 American Society for Clinical Pharmacology and Therapeutics (ASCPT) Annual Meeting, and conducted by the Medco Research Institute, claims that cancer drugs taken orally which hit enzymes in tumor cells may have been effective in the past for reducing the amount of time patients had to stay at centers to receive their chemotherapy, but new evidence shows that when they are taking other medicines, in addition to the oral cancer drugs, they can away fro” View full resource at qualitypointtech.net
Most Recently Shared on March 17, 2012 at 10:00 pm By:
Oral Cancer Drugs Not Effective When Mixed With Some Other Medications: A study, which is being presented at the 2... http://t.co/VK3t2LKh
Study: Common drugs interfere with cancer therapies - Related Stories - AANP SmartBrief
smartbrief.com — “Medco Health Solutions researchers found that many patients using oral cancer drugs also known as kinase inhibitors are also taking other medications that could limit effectiveness or heighten side effects from the anticancer treatments. Most of the cancer drug prescriptions came from oncologists…” View full resource at smartbrief.com
Most Recently Shared on March 17, 2012 at 3:11 pm By:
Study: Common #drugs interfere with #cancer therapies. #risk #patient http://t.co/f0IaqQr7
Oral BRAF inhibitor can extend survival to 16 months for patients with MM
news-medical.net — “An international team of researchers from the United States and Australia, including researchers at Moffitt Cancer Center in Tampa, Fla., have found that the oral BRAF inhibitor vemurafenib (PLX4032) when tested in a phase II clinical trial offered a high rate of response in patients with previously treated metastatic melanoma and who had the BRAF mutation.” View full resource at news-medical.net
Most Recently Shared on March 17, 2012 at 9:26 am By:
Oral BRAF inhibitor can extend survival to 16 months for patients with MM: An international team of researchers ... http://t.co/tM2N1Vwa
Response Rate High for Some Patients with Metastatic Melanoma Treated with Vemurafenib
newswise.com — “An international team of researchers from the United States and Australia, including researchers at Moffitt Cancer Center, have found that the oral BRAF inhibitor vemurafenib (PLX4032) when tested in a phase II clinical trial offered a high rate of response in patients with previously treated metastatic melanoma and who had the BRAF mutation. More than 50 percent of the patients in the trial had positive, prolonged responses and a median survival of almost 16 months.” View full resource at newswise.com
Most Recently Shared on March 16, 2012 at 4:47 pm By:
#health news: Response Rate High for Some Patients with Metastatic Melanoma Treated with Vemurafenib http://t.co/NOOLgphV
Response Rate High for Some Patients with Metastatic Melanoma Treated with Vemurafenib
newswise.com — “An international team of researchers from the United States and Australia, including researchers at Moffitt Cancer Center, have found that the oral BRAF inhibitor vemurafenib (PLX4032) when tested in a phase II clinical trial offered a high rate of response in patients with previously treated metastatic melanoma and who had the BRAF mutation. More than 50 percent of the patients in the trial had positive, prolonged responses and a median survival of almost 16 months.” View full resource at newswise.com
Most Recently Shared on March 16, 2012 at 4:42 pm By:
newswise Health Communicator and Health News
Response Rate High for Some Patients with Metastatic Melanoma Treated with Vemurafenib http://t.co/J4PYO8lL
Common medicines may cut cancer drug potency: study
health.yahoo.net — “(Reuters) - Many patients taking a widely prescribed class of oral cancer drugs are also using a variety of medications that could reduce the effectiveness of the cancer treatment or increase its toxic side effects, according to research by Medco Health Solutions Inc.” View full resource at health.yahoo.net
Most Recently Shared on March 16, 2012 at 1:05 pm By:
Jane Anderson Healthy Eating Advisor
Common medicines may cut cancer drug potency: study http://t.co/428PyYYx
Common medicines may cut cancer drug potency | Fox News
foxnews.com — “Many patients taking a widely prescribed class of oral cancer drugs are also using a variety of medications that could reduce the effectiveness of the cancer treatment or increase its toxic side effects, according to research” View full resource at foxnews.com
Most Recently Shared on March 16, 2012 at 12:43 pm By:
Common medicines may cut cancer drug potency: Many patients taking a widely prescribed class of oral cancer drug... http://t.co/Gwl2NyE7
Common medicines may cut cancer drug potency: study - Yahoo! News
news.yahoo.com — “From Yahoo! News: (Reuters) - Many patients taking a widely prescribed class of oral cancer drugs are also using a variety of medications that could reduce the effectiveness of the cancer treatment or increase its toxic side effects, according to research by Medco Health Solutions Inc. For example, 43 percent of patients taking the highly effective leukemia drug Gleevec were also on another medicine that could diminish its efficacy, while 68 percent were taking something that could potentially r” View full resource at news.yahoo.com
Most Recently Shared on March 16, 2012 at 5:25 am By:
Kidney Cancer Health Executive
Common medicines may cut kidney cancer drug potency http://t.co/SOyaBzlK
Common medicines may cut cancer drug potency: study - Yahoo! News
news.yahoo.com — “From Yahoo! News: (Reuters) - Many patients taking a widely prescribed class of oral cancer drugs are also using a variety of medications that could reduce the effectiveness of the cancer treatment or increase its toxic side effects, according to research by Medco Health Solutions Inc. For example, 43 percent of patients taking the highly effective leukemia drug Gleevec were also on another medicine that could diminish its efficacy, while 68 percent were taking something that could potentially r” View full resource at news.yahoo.com
Most Recently Shared on March 16, 2012 at 5:21 am By:
Common medicines may cut cancer drug potency: study: (Reuters) - Many patients taking a widely prescribed class ... http://t.co/6gY7a0Gg
One in Two Have Never Heard of Oral Cancer | Oral Cancer News
oralcancernews.org — “One in Two Have Never Heard of Oral Cancer | Oral Cancer News” View full resource at oralcancernews.org
Most Recently Shared on March 12, 2012 at 2:57 pm By:
Fair treatment for all cancer patients - baltimoresun.com
baltimoresun.com — “Cancer treatment: Those who need oral chemotherapy should not have to pay vastly more than patients on IV drugs” View full resource at baltimoresun.com
Most Recently Shared on February 29, 2012 at 2:49 pm By:
elaine schattner Hematologist, Physician, Doctor, Internist, and Oncologist
v @ASCO: Physician Calls for Fairness, Eliminating Out-Of-Pocket Cost Disparities For Cancer Drugs, Baltimore Sun - http://t.co/Qw8RQDoC
Mount Sinai Medical Center - HPV --> Oral Cancer? | Facebook
facebook.com — “Mount Sinai Medical Center - Mount Sinai Hospital is one of the nation’s oldest, largest, and most respected hospitals. Mount Sinai ranked 16th in U.S. News Health's 2011-2012 America's Best Hospitals and topped the 2011 New York Magazine's Best Doctors List with 209 physicians. - Mission: Our Mission is to provide excellent patient care, educate physicians and scientists, support innovative research, disseminate knowledge and promote the good health of the community, and the crea” View full resource at facebook.com
Most Recently Shared on December 2, 2011 at 3:52 pm By:
ENT and Allergy Physician Group
Check out this facebook page! http://t.co/8SAjnCIm via @AddThis
New Clinical Research Study on Head and Neck Cancer
sanfordhealth.org — “New Clinical Research Study on Head and Neck Cancer” View full resource at sanfordhealth.org
Most Recently Shared on November 8, 2011 at 11:20 pm By:
Sanford Health Healthcare System
Sanford clinical study for oral cancer therapy is now open for enrollment. Learn more http://t.co/hKW4eFCE #clinicaltrial #sanfordresearch
HPV Vaccination Could Reduce the Number of Screening Procedures | Oral Cancer News
oralcancernews.org — “HPV Vaccination Could Reduce the Number of Screening Procedures | Oral Cancer News” View full resource at oralcancernews.org
Most Recently Shared on November 8, 2011 at 10:45 pm By:
Advertisement
